Antios Therapeutics Employee Directory
Biotechnology ResearchGeorgia, United States0-1 Employees
Antios Therapeutics is a clinical-stage biotechnology company focused on developing therapies for viral diseases, with a particular emphasis on hepatitis B. It is advancing ATI-2173 as its lead oral agent, aiming to address chronic HBV infection with a potentially curative treatment approach. Based in Atlanta, Georgia, the company operates in the biotechnology research sector. Its target is patients living with chronic hepatitis B and the clinicians who manage their care, seeking a durable, combination therapy option. The organization has discussed ATI-2173 at HBV-focused industry forums, such as Hep DART 2021.